Immunodiagnostic Systems

IDS is a global medical diagnostics business dedicated to the development and provision of innovative automated and manual assays. Our development focus is in the clinical areas of bone and calcium metabolism, growth, hypertension and chronic kidney disease. Our IDS-iSYS system is designed with the flexibility to accommodate unique and challenging requirements, the IDS-iSYS automation brings testing efficiency and uncompromised quality to specialty immunoassay testing. IDS provides a compact bench top system that fully automates immunoassay testing. IDS has its global headquarters in the UK, and has subsidiaries in the USA, Germany, France, and Denmark. Other markets, including key diagnostic markets of Spain, Italy, Australia, and Japan, are serviced by a network of highly qualified and experienced distributors within each territory.
Boldon Colliery, GB
336 (est)

Immunodiagnostic Systems Locations

Boldon Colliery, GB
Gaithersburg, US

Immunodiagnostic Systems Metrics

Immunodiagnostic Systems Summary

Founding Date


Market capitalization

£53 M

Closing share price


Immunodiagnostic Systems Financials

FY, 2014FY, 2015FY, 2016


£52.3 M£45.4 M£38.3 M

Revenue growth, %


Gross profit

£35.6 M£28.3 M£22.5 M

Gross profit Margin, %


Operating expense total

£27.3 M£25.1 M£59.3 M

Immunodiagnostic Systems Market Value History

Immunodiagnostic Systems News

Immunodiagnostic Systems Company Life